|
|
|
|
Vol. 15, Issue 2, 801-814, February 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ecki
ochaThe Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Submitted August 13, 2003;
Revised October 3, 2003;
Accepted October 21, 2003
Monitoring Editor: Keith Mostov
The entry of exogenous fibroblast growth factor 2 (FGF-2) to the cytosolic/nuclear compartment was studied and compared with the translocation mechanism used by FGF-1. To differentiate between external and endogenous growth factor, we used FGF-2 modified to contain a farnesylation signal, a CaaX-box. Because farnesylation occurs only in the cytosol and nucleoplasm, farnesylation of exogenous FGF-2-CaaX was taken as evidence that the growth factor had translocated across cellular membranes. We found that FGF-2 translocation occurred in endothelial cells and fibroblasts, which express FGF receptors, and that the efficiency of translocation was increased in the presence of heparin. Concomitantly with translocation, the 18-kDa FGF-2 was N-terminally cleaved to yield a 16-kDa form. Translocation of FGF-2 required PI3-kinase activity but not transport through the Golgi apparatus. Inhibition of endosomal acidification did not prevent translocation, whereas dissipation of the vesicular membrane potential completely blocked it. The data indicate that translocation occurs from intracellular vesicles containing proton pumps and that an electrical potential across the vesicle membrane is required. Translocation of both FGF-1 and FGF-2 occurred during most of G1 but decreased shortly before the G1
S transition. A common mechanism for FGF-1 and FGF-2 translocation into cells is postulated.
Abbreviations used: FGF, fibroblast growth factor; MAP-kinase, mitogen-activated protein kinase; TCA, trichloroacetic acid.
* Corresponding author. E-mail address: olsnes{at}radium.uio.no.
This article has been cited by other articles:
![]() |
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al. Nuclear translocation of urokinase-type plasminogen activator Blood, July 1, 2008; 112(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sorensen, Y. Zhen, M. Zakrzewska, E. M. Haugsten, S. Walchli, T. Nilsen, S. Olsnes, and A. Wiedlocha Phosphorylation of Fibroblast Growth Factor (FGF) Receptor 1 at Ser777 by p38 Mitogen-Activated Protein Kinase Regulates Translocation of Exogenous FGF1 to the Cytosol and Nucleus Mol. Cell. Biol., June 15, 2008; 28(12): 4129 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nilsen, K. R. Rosendal, V. Sorensen, J. Wesche, S. Olsnes, and A. Wiedlocha A Nuclear Export Sequence Located on a beta-Strand in Fibroblast Growth Factor-1 J. Biol. Chem., September 7, 2007; 282(36): 26245 - 26256. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sorensen, A. Wiedlocha, E. M. Haugsten, D. Khnykin, J. Wesche, and S. Olsnes Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail J. Cell Sci., October 15, 2006; 119(20): 4332 - 4341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Dupree, S. R. Pollack, E. M. Levine, and C. T. Laurencin Fibroblast Growth Factor 2 Induced Proliferation in Osteoblasts and Bone Marrow Stromal Cells: A Whole Cell Model Biophys. J., October 15, 2006; 91(8): 3097 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wesche, J. Malecki, A. Wiedlocha, C. S. Skjerpen, P. Claus, and S. Olsnes FGF-1 and FGF-2 Require the Cytosolic Chaperone Hsp90 for Translocation into the Cytosol and the Cell Nucleus J. Biol. Chem., April 21, 2006; 281(16): 11405 - 11412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Joliot Transduction Peptides Within Naturally Occurring Proteins Sci. Signal., December 6, 2005; 2005(313): pe54 - pe54. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Millette, B. H. Rauch, O. Defawe, R. D. Kenagy, G. Daum, and A. W. Clowes Platelet-Derived Growth Factor-BB-Induced Human Smooth Muscle Cell Proliferation Depends on Basic FGF Release and FGFR-1 Activation Circ. Res., February 4, 2005; 96(2): 172 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wiedlocha, T. Nilsen, J. Wesche, V. Sorensen, J. Malecki, E. Marcinkowska, and S. Olsnes Phosphorylation-regulated Nucleocytoplasmic Trafficking of Internalized Fibroblast Growth Factor-1 Mol. Biol. Cell, February 1, 2005; 16(2): 794 - 810. [Abstract] [Full Text] [PDF] |
||||